Health Trials

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

ConditionsMyotonic DystrophyFacioscapulohumeral Muscular DystrophyMuscular DystrophyMyotonic Dystrophy Type 1Myotonic Dystrophy Type 2Congenital Myotonic DystrophyPROMM (Proximal Myotonic Myopathy)Steinert's DiseaseMyotonic Muscular Dystrophy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Rochester

About this trial

Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are inherited disorders characterized by progressive muscle weakness and loss of muscle tissue. The purpose of this registry is to connect people with DM or FSHD with researchers studying these diseases. The registry will offer individuals with DM and FSHD an opportunity to participate in research that focuses of their diseases. The registry will also help scientists to accomplish research on DM and FSHD and to distribute their findings to patients and care providers.

Eligibility criteria

Qualifiers

Diagnosed with DM, FSHD, or related diseases or are an unaffected family member of someone diagnosed with one of these diseases

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

University of Rochester

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Source ClinicalTrials.gov